Vicarious Surgical Inc
NYSE:RBOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vicarious Surgical Inc
NYSE:RBOT
|
US |
|
HDFC Bank Ltd
NYSE:HDB
|
IN |
|
Pentair PLC
NYSE:PNR
|
UK |
|
M
|
Marks and Spencer Group PLC
XMUN:MA6
|
UK |
|
Polski Koncern Naftowy Orlen SA
WSE:PKN
|
PL |
|
Comtech Telecommunications Corp
NASDAQ:CMTL
|
US |
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
P
|
PIK Spetsializirovannyi Zastroyshchik PAO
MOEX:PIKK
|
RU |
|
Alps Alpine Co Ltd
TSE:6770
|
JP |
|
Kodal Minerals PLC
LSE:KOD
|
UK |
|
Rakus Co Ltd
TSE:3923
|
JP |
|
ENEOS Holdings Inc
TSE:5020
|
JP |
|
Multi Commodity Exchange of India Ltd
NSE:MCX
|
IN |
|
A
|
Aurora Energy Metals Ltd
ASX:1AE
|
AU |
Wall St Price Targets
RBOT Price Targets Summary
Vicarious Surgical Inc
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RBOT's stock price target?
Not Available
RBOT does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Vicarious Surgical Inc?
Projected CAGR
12%
The compound annual growth rate for Revenue over the next 4 years is 12%.